Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
IASLC Academy
IASLC Academy
Amazing Case Race 2024
Publications, Resources & Guidelines
News
News
ILCN
WCLC 2024 News
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 205 - 216 items out of 372 results
ILCN article
Increasing Evidence Demonstrates the Usefulness of ctDNA
ILCN article
Education Award Recipients Recognized at Latin America Conference
ILCN article
TTLC 2023 Showcases Early Ongoing Trial Data, Newest Therapies
ILCN article
In Brief for Feb. 22, 2023
ILCN article
TTLC Keynote Speaker Explores Progress, Potential Breakthroughs of SCLC Therapies
ILCN article
Experts Debate TKI Use After Disease Progression for Patients with EGFR Mutations
ILCN article
Scenes from TTLC 2023
ILCN article
ILCN Editor Dr. Corey J. Langer Reflects on the ‘Fantastic Voyage’ From Nihilism to Hope in Thoracic Oncology
ILCN article
Specialists Debate the Merits of Lorlatinib as a Universal First-Line Treatment for ALK+ Patients
ILCN article
Study Explores First-Line Osimertinib for NSCLC Patients with Uncommon EGFR Mutations
ILCN article
New Texas Lung Cancer Conference Planned with Busy Clinicians in Mind
ILCN article
Mesothelioma Pioneer Delivers 2023 Heine H. Hansen Keynote Lecture
Pagination
First
First page
‹
Previous page
…
14
15
16
17
18
19
20
21
22
…
›
Next page
Last
Last page